About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Trial of Iressa in Prostate Cancer Patients

NCT00265070·4 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

18–any

Sex

MALE

Healthy volunteers

Not accepted

You may be eligible if

Removal of prostate for prostate cancer
Raised level of prostate specific antigen (PSA) post-surgery
Can have received some radiation therapy

You may not be if

Any after surgery male hormone blocking therapy.
Low white blood cell count
Abnormal liver function test

The record

StatusCompleted

PhasePhase 2

Taking part80

StartedJan 2003

UpdatedFeb 5, 2013

Conditions

Prostate Cancer

Where4

Research Site
Vancouver, British Columbia, Canada
Research Site
London, Ontario, Canada
Research Site
Toronto, Ontario, Canada

Clareo Health | Trial of Iressa in Prostate Cancer Patients